ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) Revenue
Biotechnology Research • • 1-10 Employees
$
ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at ISMiT student group (Industry Strategies for Microbiome-based Therapeutics)
Heather Emery
Vice President
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Keywords | Industry, Probiotics, Therapeutics, Microbiome, Metagenomics, Metabolic Diseases |
| Founded | 2023 |
| Employees | 1-10 |
About ISMiT student group (Industry Strategies for Microbiome-based Therapeutics)
ISMiT (Industry Strategies for Microbiome-based Therapeutics) is an interest group made up of researchers at the University of Wisconsin-Madison who seek to build connections and foster collaborations with innovative industry leaders in the microbial therapeutic and microbiome research space.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) has never raised funding before.
Canada
Germany
Frequently asked questions
ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) is located in XX.
ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
ISMiT student group (Industry Strategies for Microbiome-based Therapeutics) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
